TargetMol

Roslin 2 bromide

Product Code:
 
TAR-T24730
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T24730-1mg1mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24730-5mg5mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24730-1mL1 mL * 10 mM (in DMSO)£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24730-10mg10mg£297.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24730-25mg25mg£470.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24730-50mg50mg£651.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24730-100mg100mg£863.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24730-500mg500mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Roslin 2 bromide is a p53 reactivator that disrupts the binding of FAK and p5Roslin 2 bromide exhibits anticancer effects.
CAS:
29574-21-8
Formula:
C13H19BrN4
Molecular Weight:
311.227
Pathway:
Cytoskeletal Signaling; Angiogenesis; Tyrosine Kinase/Adaptors; Apoptosis
Purity:
0.98
SMILES:
[Br-].C(c1ccccc1)[N+]12CN3CN(CN(C3)C1)C2
Target:
FAK; p53

References

1. Learmount J, Callaby R, Taylor M. An observational study of ewe treatments at lambing on early infection in lambs on UK sheep farms. Vet Parasitol. 2018 Apr 15;253:55-59. doi: 10.1016/j.vetpar.2018.02.026. Epub 2018 Feb 12. PubMed PMID: 29605004. 2. Takahashi M, McCartney E, Knox A, Francesch M, Oka K, Wada K, Ideno M, Uno K, Koz?owski K, Jankowski J, Gracia MI, Morales J, Kritas SK, Esteve-Garcia E, Kamiya S. Effects of the butyric acid-producing strain Clostridium butyricum MIYAIRI 588 on broiler and piglet zootechnical performance and prevention of necrotic enteritis. Anim Sci J. 2018 Mar 30. doi: 10.1111/asj.13006. [Epub ahead of print] PubMed PMID: 29603498. 3. Amengual Batle P, Rusbridge C, Nuttall T, Heath S, Marioni-Henry K. Feline hyperaesthesia syndrome with self-trauma to the tail: retrospective study of seven cases and proposal for integrated multidisciplinary diagnostic approach. J Feline Med Surg. 2018 Mar 1:1098612X18764246. doi: 10.1177/1098612X18764246. [Epub ahead of print] PubMed PMID: 29595359. 4. Porphyre T, Rich KM, Auty HK. Assessing the Economic Impact of Vaccine Availability When Controlling Foot and Mouth Disease Outbreaks. Front Vet Sci. 2018 Mar 13;5:47. doi: 10.3389/fvets.2018.00047. eCollection 2018. PubMed PMID: 29594161; PubMed Central PMCID: PMC5859371.